The upgrade from Reduce to Hold indicates a more positive outlook for BMY, which could potentially lead to an increase in demand for the stock. However, the lowering of the price target from $55 to $53 suggests that the stock may be overvalued at its current price, which could put downward pressure on the stock price. The net effect of these two factors is uncertain, hence the neutral score.